Procoagulant expression in platelets and defects leading to clinical disorders

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 19, Issue 12, 1999, Pages 2841-2846

  Solum, Nils Olav ^a,b  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Coagulation; Hemostasis; Microvesicles; Platelets

Indexed keywords

PROCOAGULANT;

BLEEDING TENDENCY; BLOOD CLOTTING DISORDER; HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCOTT SYNDROME; SHORT SURVEY; THROMBOCYTE ACTIVATION; THROMBOCYTE MEMBRANE;

EID: 0033373546     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.19.12.2841     Document Type: Short Survey

References (40)

1. Brass LF, Hoxie JA, Manning DR. Signaling through G proteins and G protein-coupled receptors during platelet activation. Thromb Haemost. 1993;70:217-223.
2. Watson SP, Gibbins J. Collagen receptor signalling in platelets: extending the role of ITAM. Immunol Today. 1998;19:260-264.
3. Bouchard BA, Catcher CS, Trash BR, Adida C, Tracy PB. Effector cell protease receptor-1, a platelet activation-dependent membrane protein, regulates prothrombinase-catalyzed thrombin generation. J Biol Chem. 1997;272:9244-9251.
4. Janeway CM, Rivard GE, Tracy, PB, Mann KG. Factor V Quebec revisited. Blood. 1996;87:3571-3578.
5. Holme PA, Brosstad F, Solum NO. Platelet-derived microvesicles and activated platelets express factor Xa activity. Blood Coagul Fibrinolysis. 1995;6:302-310.
6. Bevers EM, Comfurius P, Zwaal RFA. Platelet procoagulant activity: physiological significance and mechanisms of exposure. Blood Rev. 1991;5:146-154.
7. Seigneuret M, Deavaux PF. ATP-dependent asymmetric distribution of spin-labeled phospholipids in the erythrocyte membrane: relation to shape changes. Proc Natl Acad Sci USA. 1984;81:3751-3755.
8. Zwaal RFA, Schroit AJ. Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood. 1997;89:1121-1132.
9. Zhou Q, Zhao J, Stout JG, Luhm RA, Wiedmer T, Sims PJ. Molecular cloning of human plasma membrane phospholipid scramblase: a protein mediating transbilayer movement of plasma membrane phospholipids. J Biol Chem. 1997;272:18240-18244.
10. Comfurius P, Williamson P, Smeets EF, Schlegel RA, Bevers EM, Zwaal RFA. Reconstitution of phospholipid scramblase activity from human blood platelets. Biochemistry: 1996;35:7631-7634.
11. 2+-activated transbilayer movement of membrane phospholipids. Biochemistry. 1998; 37:6361-6366.
12. 2+-accelerated transbilayer movement of membrane phospholipids. Biochemistry: 1998;37: 2356-2360.
13. Weiss HJ, Lages B. Family studies in Scott syndrome. Blood. 1997;90: 475-476.
14. Toti F, Satta N, Fressinaud E, Meyer D, Freyssinet JM. Scott syndrome, characterized by impaired transmembrane migration of procoagulant phosphatidylserine and hemorrhagic complications, is an inherited disorder. Blood. 1996;87:1409-1415.
15. 2+-dependent transbilayer migration of membrane phospholipids. J Clin Invest. 1997;99:2232-2238.
16. 2+-induced microvesiculation and deficient expression of procoagulant activity in erythrocytes from a patient with a bleeding disorder: a study of the red blood cells of Scott syndrome. Blood. 1992;79:380-388.
17. Gaffet P, Bettache N, Bienvenüe A. Transverse redistribution of phospholipids during human platelet activation: evidence for a vectorial outflux specific to aminophospholipids. Biochemistry: 1995;34: 6762-6769.
18. 2+-ATPase inhibitors. Biochemistry: 1995;34:11625-11634.
19. Dachary-Prigent J, Pasquet JM, Fressinaud E, Toti F, Freyssinet JM, Nurden AT. Aminophospholipid exposure, microvesiculation and abnormal protein tyrosine phosphorylation in the platelets of a patient with Scott syndrome: a study using physiologic agonists and local anaesthetics. Br J Haematol. 1997;99:959-967.
20. Sims PJ, Faioni EM, Wiedmer T, Shattil SJ. Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity. J Biol Chem. 1988;263:18205-18212.
21. Pasquet JM, Dachary-Prigent J, Nurden AT. Microvesicle release is associated with extensive protein tyrosine dephosphorylation in platelets stimulated by A23187 or a mixture of thrombin and collagen. Biochem J. 1998;333:591-599.
22. Fox JEB, Reynolds CC, Austin CD. The role of calpain in stimulus-response coupling: evidence that calpain mediates agonist-induced expression of procoagulant activity in platelets. Blood. 1990;76: 2510-2519.
23. 2T purinoreceptors in human platelets. J Biol Chem. 1996;271:2879-2881.
24. Weiss HJ, Lages B. Platelet prothrombinase activity and intracellular calcium responses in patients with storage pool deficiency, glycoprotein IIb-IIIa deficiency, or impaired platelet coagulant activity: a comparison with Scott syndrome. Blood. 1997;89:1599-1611.
25. Hayward CPM, Rivard GE, Kane WH, Drouin J, Zheng S, Moore JC, Kelton JG. An autosomal dominant, qualitative platelet disorder associated with multimerin deficiency, abnormalities in platelet factor V, thrombospondin, von Willebrand factor and fibrinogen, and an epinephrine aggregation defect. Blood. 1996;87:4967-4978.
26. Weiss HJ, Vicic WJ, Lages BA, Rogers J. Isolated deficiency of platelet procoagulant activity. Am J Med. 1979;67:206-213.
27. Ahmad SS, Rawala-Sheik R, Ashby B, Walsh PN. Platelet receptor-mediated factor X activation by factor IXa: high-affinity factor IX receptors induced by factor VIII are deficient on platelets in Scott syndrome. J Clin Invest. 1989;84:824-828.
28. Rosing J, Bevers EM, Comfurius P, Hemker HC, v. Dieijen G, Weiss HJ, Zwaal RFA. Impaired factor X and prothrombin activation associated with decreased phospholipid exposure in platelets from a patient with a bleeding disorder. Blood. 1985;65:1557-1561.
29. Weiss HJ. Scott syndrome: a disorder of platelet coagulant activity. Semin Hematol. 1994;31:312-319.
30. Minkoff IM, Wu KK, Walasek J, Lightfood B, Smith-McKearn C. Bleeding disorder due to an isolated platelet factor 3 deficiency. Arch Intern Med. 1980;140:366-367.
31. Castaman G, Yu-Feng L, Battistin E, Rodeghiero F. Characterization of a novel bleeding disorder with isolated prolonged bleeding time and deficiency of platelet microvesicle generation. Br J Haematol. 1997;96: 458-463.
32. Stormorken H, Sjaastad O, Langslet A, Sulg I, Egge K, Diderichsen J. A new syndrome: thrombocytopathia, muscle fatigue, asplenia, migraine, dyslexia and ichthyosis. Clin Genet. 1985;28:367-374.
33. Stormorken H, Holmsen H, Sund R, Sakariassen KS, Hovig T, Jellum E, Solum NO. Studies on the haemostatic defect in a complicated syndrome: an inverse Scott syndrome platelet membrane abnormality? Thromb Haemost. 1995;74:1244-1251.
34. Bevers EM, Comfurius P, Nieuwenhuis HK, Levy-Toledano S, Enouf J, Belluci S, Caen JP, Zwaal RFA. Platelet prothrombin converting activity in hereditary disorders of platelet function. Br J Haematol. 1986;63: 335-345.
35. Jy W, Horstman LL, Arce M, Ahn YS. Clinical significance of platelet microparticles in autoimmune thrombocytopenias. J Lab Clin Med. 1992; 119:334-345.
36. Holme PA, Solum NO, Brosstad F. Røger M, Abdelnoor M. Demonstration of platelet-derived microvesicles in blood from patients with activated coagulation and fibrinolysis using a filtration technique and Western blotting. Thromb Haemost. 1994;72:666-671.
37. Holme PA, Müller F, Solum NO, Brosstad F, Frøland SS, Aukrust P. Enhanced activation of platelets with abnormal release of RANTES in human immunodeficiency virus type 1 infection. FASEB J. 1998;12: 79-89.
38. Holme PA, Solum NO, Brosstad F, Pedersen T, Kveine M. Microvesicles bind soluble fibrinogen, adhere to immobilized fibrinogen, and coaggregate with platelets. Thromb Haemost. 1998;79:389-394.
39. Casciola-Rosen L, Rosen A, Petri M, Schlissel M. Surface blebs on apoptotic cells are sites of enhanced procoagulant activity: implications for coagulation events and antigenic spread in systemic lupus erythematosus. Proc Natl Acad Sci U S A. 1996;93:1624-1629.
40. Henn V, Slupsky JR, Gräfe M, Anagnostopoulos I, Förster R, Müller-Berghaus G, Kroczek RA. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature. 1998;391:591-594.